TCHF II has already allocated 60% of the $130 million corpus raised last year. It has concluded seven investments to date. The current TCHF II portfolio is strategically diversified across domestic and export pharmaceuticals, cancer care clinics, dialysis centers, integrated regional diagnostic chains, and digital healthcare.
The funding is done through Tata Capital Healthcare Fund II (TCHF II), the healthcare focused private equity fund of Tata Capital. About 90% of the funding will be for growth and 10% will provide exit to certain angel investors. Founded by nephrologists Jatin Kothari and Viswanath Billa, AKC has raised funds from founders and angel investors.